|  | 
								
									|  | 
								
									| 
										
											
												| 
													
														
															| 
															Check out this detailed presentation on how Nanoforming can help improve the performance of your molecule by increasing drug loads for smaller/fewer pills or long-acting injectables, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation while boosting patient adherence.   |  |  | 
								
									|  | 
								
									| 
										
											
												| 
													
														
															| 
															Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a unique, new, state-of-the-art multimillion euro nanotechnology facility to produce GMP nanoparticles as small as 10 nanometers. Nanoform is the only company in the world to offer this capability.   |  |  | 
								
									|  | 
								
									| 
										
											
												| 
													
														
															| 
															Through using nanocrystalline formulations of new drugs, and reformulating already-marketed ASD products, this webinar demonstrates how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.   |  |  | 
								
									|  | 
								
									|  |